{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T00:54:46Z","timestamp":1790902486143,"version":"4.1.0"},"reference-count":37,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,15]],"date-time":"2025-03-15T00:00:00Z","timestamp":1741996800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004336","name":"Novartis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012112","name":"Swedish Orphan Biovitrum","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012112","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ero.eular.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["EULAR Rheumatology Open"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.ero.2025.03.003","type":"journal-article","created":{"date-parts":[[2025,4,28]],"date-time":"2025-04-28T07:22:41Z","timestamp":1745824961000},"page":"100006","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Burden of fatigue in cryopyrin-associated periodic syndromes"],"prefix":"10.1016","volume":"2","author":[{"given":"\u00d6zlem","family":"Satirer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yilmaz","family":"Satirer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6920-1933","authenticated-orcid":false,"given":"Anne-Kathrin","family":"Gellner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanne M.","family":"Benseler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6365-6598","authenticated-orcid":false,"given":"Jasmin B.","family":"Kuemmerle-Deschner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ero.2025.03.003_bib0001","doi-asserted-by":"crossref","first-page":"128","DOI":"10.3390\/jcm10010128","article-title":"Diagnosis and management of the cryopyrin-associated periodic syndromes (CAPS): what do we know today?","volume":"10","author":"Welzel","year":"2021","journal-title":"J Clin Med"},{"issue":"1","key":"10.1016\/j.ero.2025.03.003_bib0002","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3109\/14397595.2015.1069459","article-title":"Impact of IL-1 inhibition on fatigue associated with autoinflammatory syndromes","volume":"26","author":"Yadlapati","year":"2016","journal-title":"Mod Rheumatol"},{"issue":"6","key":"10.1016\/j.ero.2025.03.003_bib0003","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1080\/14397595.2018.1427459","article-title":"Fatigue in pediatric patients with familial Mediterranean fever","volume":"28","author":"\u00d6zdel","year":"2018","journal-title":"Mod Rheumatol"},{"issue":"6","key":"10.1016\/j.ero.2025.03.003_bib0004","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1093\/rheumatology\/keq454","article-title":"Biological mechanisms of chronic fatigue","volume":"50","author":"Norheim","year":"2011","journal-title":"Rheumatology (Oxford)"},{"issue":"6","key":"10.1016\/j.ero.2025.03.003_bib0005","doi-asserted-by":"crossref","first-page":"R202","DOI":"10.1186\/ar3535","article-title":"Sustained remission of symptoms and improved health-related quality of life in patients with cryopyrin-associated periodic syndrome treated with canakinumab: results of a double-blind placebo-controlled randomized withdrawal study","volume":"13","author":"Kon\u00e9-Paut","year":"2011","journal-title":"Arthritis Res Ther"},{"issue":"8","key":"10.1016\/j.ero.2025.03.003_bib0006","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.3899\/jrheum.131291","article-title":"Longterm followup of quality of life in patients with cryopyrin-associated periodic syndrome treated with canakinumab, an anti-interleukin 1\u03b2 monoclonal antibody","volume":"41","author":"Marsaud","year":"2014","journal-title":"J Rheumatol"},{"issue":"6","key":"10.1016\/j.ero.2025.03.003_bib0007","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1136\/annrheumdis-2016-209686","article-title":"Diagnostic criteria for cryopyrin-associated periodic syndrome (CAPS)","volume":"76","author":"Kuemmerle-Deschner","year":"2017","journal-title":"Ann Rheum Dis"},{"issue":"8","key":"10.1016\/j.ero.2025.03.003_bib0008","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1136\/annrheumdis-2019-215048","article-title":"Classification criteria for autoinflammatory recurrent fevers","volume":"78","author":"Gattorno","year":"2019","journal-title":"Ann Rheum Dis"},{"issue":"12","key":"10.1016\/j.ero.2025.03.003_bib0009","first-page":"2494","article-title":"The PedsQL Multidimensional Fatigue Scale in pediatric rheumatology: reliability and validity","volume":"31","author":"Varni","year":"2004","journal-title":"J Rheumatol"},{"issue":"5","key":"10.1016\/j.ero.2025.03.003_bib0010","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet Med"},{"issue":"2","key":"10.1016\/j.ero.2025.03.003_bib0011","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1001\/jama.298.2.217","article-title":"Palliative management of fatigue at the close of life: \u201cit feels like my body is just worn out\u201d","volume":"298","author":"Markowitz","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.ero.2025.03.003_bib0012","doi-asserted-by":"crossref","DOI":"10.3389\/fped.2022.1044170","article-title":"Approach to the child with fatigue: a focus for the general pediatrician","volume":"10","author":"De Nardi","year":"2022","journal-title":"Front Pediatr"},{"issue":"SI2","key":"10.1016\/j.ero.2025.03.003_bib0013","doi-asserted-by":"crossref","first-page":"SI152","DOI":"10.1093\/rheumatology\/keac350","article-title":"Validation of the parent global assessment as a health-related quality of life measure in juvenile idiopathic arthritis: results from ReACCh-Out","volume":"62","author":"Oen","year":"2023","journal-title":"Rheumatology (Oxford)"},{"issue":"23","key":"10.1016\/j.ero.2025.03.003_bib0014","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.1056\/NEJMoa0810787","article-title":"Use of canakinumab in the cryopyrin-associated periodic syndrome","volume":"360","author":"Lachmann","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ero.2025.03.003_bib0015","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/1477-7525-4-75","article-title":"The PedsQL Present Functioning Visual Analogue Scales: preliminary reliability and validity","volume":"4","author":"Sherman","year":"2006","journal-title":"Health Qual Life Outcomes"},{"issue":"6","key":"10.1016\/j.ero.2025.03.003_bib0016","first-page":"305","article-title":"Assessment of fatigue in cancer and non-cancer patients and in healthy individuals","volume":"1","author":"Glaus","year":"1993","journal-title":"Support Care Cancer"},{"issue":"1","key":"10.1016\/j.ero.2025.03.003_bib0017","doi-asserted-by":"crossref","first-page":"58","DOI":"10.3906\/sag-1711-167","article-title":"Fatigue and sleep in children and adolescents with juvenile idiopathic arthritis: a cross-sectional study","volume":"49","author":"Tarak\u00e7\u0131","year":"2019","journal-title":"Turk J Med Sci"},{"issue":"1","key":"10.1016\/j.ero.2025.03.003_bib0018","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2023-003890","article-title":"Long-term safety and effectiveness of canakinumab in patients with monogenic autoinflammatory diseases: results from the interim analysis of the RELIANCE registry","volume":"10","author":"Kuemmerle-Deschner","year":"2024","journal-title":"RMD Open"},{"issue":"6","key":"10.1016\/j.ero.2025.03.003_bib0019","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1056\/NEJMoa055137","article-title":"Neonatal-onset multisystem inflammatory disease responsive to interleukin-1beta inhibition","volume":"355","author":"Goldbach-Mansky","year":"2006","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/j.ero.2025.03.003_bib0020","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.1002\/art.23620","article-title":"A pilot study to evaluate the safety and efficacy of the long-acting interleukin-1 inhibitor rilonacept (interleukin-1 trap) in patients with familial cold autoinflammatory syndrome","volume":"58","author":"Goldbach-Mansky","year":"2008","journal-title":"Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.ero.2025.03.003_bib0021","doi-asserted-by":"crossref","first-page":"R34","DOI":"10.1186\/ar3266","article-title":"Canakinumab (ACZ885, a fully human IgG1 anti-IL-1\u03b2 mAb) induces sustained remission in pediatric patients with cryopyrin-associated periodic syndrome (CAPS)","volume":"13","author":"Kuemmerle-Deschner","year":"2011","journal-title":"Arthritis Res Ther"},{"issue":"8","key":"10.1016\/j.ero.2025.03.003_bib0022","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1002\/art.23687","article-title":"Efficacy and safety of rilonacept (interleukin-1 trap) in patients with cryopyrin-associated periodic syndromes: results from two sequential placebo-controlled studies","volume":"58","author":"Hoffman","year":"2008","journal-title":"Arthritis Rheum"},{"issue":"7","key":"10.1016\/j.ero.2025.03.003_bib0023","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1002\/art.34409","article-title":"Sustained response and prevention of damage progression in patients with neonatal-onset multisystem inflammatory disease treated with anakinra: a cohort study to determine three- and five-year outcomes","volume":"64","author":"Sibley","year":"2012","journal-title":"Arthritis Rheum"},{"issue":"5","key":"10.1016\/j.ero.2025.03.003_bib0024","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1002\/jlb.56.5.542","article-title":"The IL-1 receptor signaling pathway","volume":"56","author":"Kuno","year":"1994","journal-title":"J Leukoc Biol"},{"issue":"1","key":"10.1016\/j.ero.2025.03.003_bib0025","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/0006-8993(95)00194-U","article-title":"Differential effects of IL-1ra on sickness behavior and weight loss induced by IL-1 in rats","volume":"677","author":"Bluth\u00e9","year":"1995","journal-title":"Brain Res"},{"issue":"2 Suppl","key":"10.1016\/j.ero.2025.03.003_bib0026","doi-asserted-by":"crossref","first-page":"573S","DOI":"10.1093\/ajcn\/72.2.573S","article-title":"Serotonin and central nervous system fatigue: nutritional considerations","volume":"72","author":"Davis","year":"2000","journal-title":"Am J Clin Nutr"},{"issue":"1","key":"10.1016\/j.ero.2025.03.003_bib0027","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1097\/00005768-199701000-00008","article-title":"Possible mechanisms of central nervous system fatigue during exercise","volume":"29","author":"Davis","year":"1997","journal-title":"Med Sci Sports Exerc"},{"issue":"9447","key":"10.1016\/j.ero.2025.03.003_bib0028","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1016\/S0140-6736(04)17401-1","article-title":"Prevention of cold-associated acute inflammation in familial cold autoinflammatory syndrome by interleukin-1 receptor antagonist","volume":"364","author":"Hoffman","year":"2004","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.ero.2025.03.003_bib0029","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1002\/art.25057","article-title":"Long-term efficacy of the interleukin-1 receptor antagonist anakinra in ten patients with neonatal-onset multisystem inflammatory disease\/chronic infantile neurologic, cutaneous, articular syndrome","volume":"62","author":"Neven","year":"2010","journal-title":"Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.ero.2025.03.003_bib0030","doi-asserted-by":"crossref","first-page":"R33","DOI":"10.1186\/ar4184","article-title":"The schedule of administration of canakinumab in cryopyrin associated periodic syndrome is driven by the phenotype severity rather than the age","volume":"15","author":"Caorsi","year":"2013","journal-title":"Arthritis Res Ther"},{"issue":"4","key":"10.1016\/j.ero.2025.03.003_bib0031","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1093\/rheumatology\/kev416","article-title":"Real-life effectiveness of canakinumab in cryopyrin-associated periodic syndrome","volume":"55","author":"Kuemmerle-Deschner","year":"2016","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"10.1016\/j.ero.2025.03.003_bib0032","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.autrev.2012.07.016","article-title":"Amyloidosis in autoinflammatory syndromes","volume":"12","author":"Obici","year":"2012","journal-title":"Autoimmun Rev"},{"issue":"2","key":"10.1016\/j.ero.2025.03.003_bib0033","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1037\/a0035216","article-title":"Family and parent influences on pediatric chronic pain: a developmental perspective","volume":"69","author":"Palermo","year":"2014","journal-title":"Am Psychol"},{"issue":"10","key":"10.1016\/j.ero.2025.03.003_bib0034","doi-asserted-by":"crossref","first-page":"ofab440","DOI":"10.1093\/ofid\/ofab440","article-title":"Long COVID and post-infective fatigue syndrome: a review","volume":"8","author":"Sandler","year":"2021","journal-title":"Open Forum Infect Dis"},{"issue":"5","key":"10.1016\/j.ero.2025.03.003_bib0035","doi-asserted-by":"crossref","DOI":"10.1001\/jamahealthforum.2022.1809","article-title":"The costs of long COVID","volume":"3","author":"Cutler","year":"2022","journal-title":"JAMA Health Forum"},{"issue":"3","key":"10.1016\/j.ero.2025.03.003_bib0036","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/s41579-022-00846-2","article-title":"Long COVID: major findings, mechanisms and recommendations","volume":"21","author":"Davis","year":"2023","journal-title":"Nat Rev Microbiol"},{"issue":"1","key":"10.1016\/j.ero.2025.03.003_bib0037","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s00296-017-3882-3","article-title":"Ulutatar F. Fatigue in familial Mediterranean fever and its relations with other clinical parameters","volume":"38","author":"Duruoz","year":"2018","journal-title":"Rheumatol Int"}],"container-title":["EULAR Rheumatology Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S3050708125000060?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S3050708125000060?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T00:18:03Z","timestamp":1790900283000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S3050708125000060"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":37,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S3050708125000060"],"URL":"https:\/\/doi.org\/10.1016\/j.ero.2025.03.003","relation":{},"ISSN":["3050-7081"],"issn-type":[{"value":"3050-7081","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Burden of fatigue in cryopyrin-associated periodic syndromes","name":"articletitle","label":"Article Title"},{"value":"EULAR Rheumatology Open","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ero.2025.03.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier B.V. on behalf of European Alliance of Associations for Rheumatology (EULAR).","name":"copyright","label":"Copyright"}],"article-number":"100006"}}